Amoy Diagnostics Co Ltd - Class A

SZSE:300685 (China)   Class A
Â¥ 18.58 (-1.8%) Jun 18
27.32
P/B:
4.18
Market Cap:
Â¥ 7.40B ($ 1.04B)
Enterprise V:
Â¥ 6.27B ($ 883.21M)
Volume:
981.30K
Avg Vol (2M):
5.20M
Trade In:
Volume:
981.30K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Amoy Diagnostics Co Ltd ( SZSE:300685 ) from 2017 to Jun 18 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Amoy Diagnostics stock (SZSE:300685) PE ratio as of Jun 18 2024 is 27.32. More Details

Amoy Diagnostics Co Ltd (SZSE:300685) PE Ratio (TTM) Chart

To

Amoy Diagnostics Co Ltd (SZSE:300685) PE Ratio (TTM) Historical Data

Total 1207
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Amoy Diagnostics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-19 27.3 2024-04-11 30.0
2024-06-18 27.8 2024-04-10 30.2
2024-06-17 27.5 2024-04-09 31.4
2024-06-14 27.1 2024-04-08 30.6
2024-06-13 27.4 2024-04-03 31.4
2024-06-12 27.3 2024-04-02 31.6
2024-06-11 27.3 2024-04-01 33.5
2024-06-07 26.5 2024-03-29 32.2
2024-06-06 26.8 2024-03-28 32.1
2024-06-05 27.2 2024-03-27 32.4
2024-06-04 27.3 2024-03-26 33.3
2024-06-03 26.8 2024-03-25 33.6
2024-05-31 27.1 2024-03-22 34.4
2024-05-30 26.9 2024-03-21 34.5
2024-05-29 26.6 2024-03-20 35.1
2024-05-28 27.1 2024-03-19 35.0
2024-05-27 27.1 2024-03-18 35.8
2024-05-24 27.4 2024-03-15 35.5
2024-05-23 27.6 2024-03-14 35.4
2024-05-22 28.5 2024-03-13 35.5
2024-05-21 28.6 2024-03-12 34.5
2024-05-20 29.2 2024-03-11 33.5
2024-05-17 29.4 2024-03-08 33.1
2024-05-16 29.1 2024-03-07 33.0
2024-05-15 30.2 2024-03-06 34.1
2024-05-14 30.6 2024-03-05 34.6
2024-05-13 30.4 2024-03-04 34.8
2024-05-10 31.3 2024-03-01 34.1
2024-05-09 32.5 2024-02-29 33.4
2024-05-08 32.5 2024-02-28 31.3
2024-05-07 32.9 2024-02-27 32.3
2024-05-06 32.6 2024-02-26 31.1
2024-04-30 32.2 2024-02-23 30.4
2024-04-29 32.2 2024-02-22 30.4
2024-04-26 31.7 2024-02-21 30.2
2024-04-25 31.0 2024-02-20 30.6
2024-04-24 31.4 2024-02-19 30.2
2024-04-23 31.3 2024-02-08 29.8
2024-04-22 32.4 2024-02-07 29.4
2024-04-19 31.0 2024-02-06 28.7
2024-04-18 32.0 2024-02-05 23.9
2024-04-17 30.9 2024-02-02 24.9
2024-04-16 29.6 2024-02-01 26.1
2024-04-15 30.1 2024-01-31 25.6
2024-04-12 30.2 2024-01-30 27.0

Amoy Diagnostics Co Ltd (SZSE:300685) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.